RSCI (Redwood Scientific Technologies) Current Accrued Expense: $0.49 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Redwood Scientific Technologies Current Accrued Expense?

Redwood Scientific Technologies RSCI Current Accrued Expense is $0.49 Mil as of Dec. 2023.

Redwood Scientific Technologies's Current Accrued Expense for the quarter that ended in Dec. 2023 was $0.49 Mil.

Redwood Scientific Technologies's quarterly Current Accrued Expense increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.14 Mil) and increased from Dec. 2022 ($0.14 Mil) to Dec. 2023 ($0.49 Mil).

Redwood Scientific Technologies's annual Current Accrued Expense increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.14 Mil) and increased from Dec. 2022 ($0.14 Mil) to Dec. 2023 ($0.49 Mil).

Redwood Scientific Technologies Current Accrued Expense Related Terms

Redwood Scientific Technologies Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies Current Accrued Expense Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
0.00 0.00 0.14 0.49

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Current Accrued Expense 0.00 0.00 0.14 0.49

Redwood Scientific Technologies Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.49 Mil mean?
Redwood Scientific Technologies (RSCI) has a Current Accrued Expense of $0.49 Mil as of Dec. 2023. Current Accrued Expense records the total amount of accrued expenses. View historical data on Redwood Scientific Technologies and its competitors.
Is Redwood Scientific Technologies' Current Accrued Expense too high?
Redwood Scientific Technologies' current Current Accrued Expense is $0.49 Mil.
How does Redwood Scientific Technologies' Current Accrued Expense compare to RAPH and FLGC?
Redwood Scientific Technologies' Current Accrued Expense of $0.49 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Redwood Scientific Technologies and its competitors. Redwood Scientific Technologies's current Current Accrued Expense is $0.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current Current Accrued Expense of $0.49 Mil. The current Current Accrued Expense is $0.49 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current Current Accrued Expense is $0.49 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.